Published in Haematologica on January 01, 2010
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA (2003) 8.18
Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med (1998) 6.88
Newborn screening for sickle cell disease: effect on mortality. Pediatrics (1988) 3.16
Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica (2007) 2.98
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood (2007) 2.36
Health-related quality of life in children with sickle cell disease: child and parent perception. Br J Haematol (2005) 2.16
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood (2007) 2.13
Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood (1996) 2.01
Vaso-occlusive painful events in sickle cell disease: impact on child well-being. Pediatr Blood Cancer (2010) 1.98
Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol (2007) 1.84
Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. Haematologica (2008) 1.71
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr (2002) 1.50
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant (2009) 1.46
Bone marrow transplantation for sickle cell disease. A study of parents' decisions. N Engl J Med (1991) 1.33
Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes. Haematologica (2006) 1.21
Children with sickle cell disease: growth and gonadal function after hematopoietic stem cell transplantation. J Pediatr Hematol Oncol (2007) 1.06
Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer. Pediatr Blood Cancer (2007) 1.00
Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints. Int J Environ Res Public Health (2009) 0.90
Posttraumatic stress disorder in children affected by sickle-cell disease and their parents. Am J Hematol (2007) 0.88
Bone involvement in sickle cell disease. Br J Haematol (2005) 2.22
Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation. Blood (2010) 2.19
The role of mesenchymal stem cells in haemopoiesis. Blood Rev (2005) 1.98
Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency. Nat Med (2006) 1.97
Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol (2007) 1.84
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood (2002) 1.83
Management of Evans syndrome. Br J Haematol (2006) 1.76
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood (2013) 1.68
Natural history of GATA1 mutations in Down syndrome. Blood (2003) 1.65
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Blood (2012) 1.64
Transfusion guidelines for neonates and older children. Br J Haematol (2004) 1.61
Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations. Blood (2008) 1.54
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Proc Natl Acad Sci U S A (2012) 1.46
Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. Br J Haematol (2009) 1.38
Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload. Blood (2006) 1.30
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma. Blood (2012) 1.27
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762. Blood (2013) 1.20
Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe. Haematologica (2007) 1.17
Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia. Blood (2003) 1.13
Haematology of Down syndrome. Arch Dis Child Fetal Neonatal Ed (2007) 1.11
Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia. Blood (2011) 1.11
Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome. Blood (2010) 1.08
Hemozoin- and 4-hydroxynonenal-mediated inhibition of erythropoiesis. Possible role in malarial dyserythropoiesis and anemia. Haematologica (2004) 1.04
Right ventricular systolic strain is altered in children with sickle cell disease. J Am Soc Echocardiogr (2012) 0.99
Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria. Blood (2013) 0.98
Factors predicting future ACS episodes in children with sickle cell anemia. Am J Hematol (2014) 0.97
Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics (2009) 0.95
Complications and treatment of patients with β-thalassemia in France: results of the National Registry. Haematologica (2009) 0.95
Does regular blood transfusion prevent progression of cerebrovascular lesions in children with sickle cell disease? Ann Hematol (2008) 0.95
Haemoglobin F modulation in childhood sickle cell disease. Br J Haematol (2008) 0.94
GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder. Br J Haematol (2005) 0.93
Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis. Early Hum Dev (2006) 0.93
RBC T activation and hemolysis in a neonatal intensive care population: implications for transfusion practice. Transfusion (2002) 0.93
Target enrichment and high-throughput sequencing of 80 ribosomal protein genes to identify mutations associated with Diamond-Blackfan anaemia. Br J Haematol (2013) 0.91
How I manage neonatal thrombocytopenia. Br J Haematol (2011) 0.90
Cord blood stem cell transplantation for haemoglobinopathies. Br J Haematol (2008) 0.89
Posttraumatic stress disorder in children affected by sickle-cell disease and their parents. Am J Hematol (2007) 0.88
Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease. Eur J Haematol (2009) 0.88
Neonatal thrombocytopenia. Early Hum Dev (2004) 0.87
[Infections in splenectomized patient]. Rev Prat (2008) 0.84
High transduction efficiency of circulating first trimester fetal mesenchymal stem cells: potential targets for in utero ex vivo gene therapy. BJOG (2002) 0.84
Acute hepatic crisis in children with sickle cell disease. J Pediatr Gastroenterol Nutr (2004) 0.83
Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients. Br J Haematol (2012) 0.82
Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. Transfusion (2007) 0.81
Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease. J Clin Invest (2015) 0.81
Characterization of first trimester fetal erythroblasts for non-invasive prenatal diagnosis. Mol Hum Reprod (2003) 0.81
Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome. Semin Fetal Neonatal Med (2012) 0.80
Changes in the maternal cytokine profile in pregnancies complicated by fetal growth restriction. Am J Reprod Immunol (2012) 0.80
Mechanism of Polycomb recruitment to CpG islands revealed by inherited disease-associated mutation. Hum Mol Genet (2013) 0.80
Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease. Pediatr Infect Dis J (2007) 0.80
A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen. Am J Hematol (2015) 0.80
Role of GATA-1s in early hematopoiesis and differences between alternative splicing in human and murine GATA-1. Blood (2010) 0.79
Age and aging in blood disorders: EHA theme of the year 2013-2014. Haematologica (2013) 0.78
Myocardial perfusion in children with sickle cell disease. Am J Cardiol (2003) 0.78
Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia. Br J Haematol (2012) 0.78
Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults. Bone (2012) 0.78
Correction of severe anaemia using immuno-regulated gene therapy is achieved by restoring the early erythroblast compartment. Br J Haematol (2006) 0.77
The expression of minichromosome maintenance protein-2 in normal and abnormal megakaryocytes and comparison with the proliferative marker Ki-67. Br J Haematol (2005) 0.77
Changes in the fetal and neonatal cytokine profile in pregnancies complicated by fetal growth restriction. Am J Reprod Immunol (2012) 0.76
Decreased morbidity in homozygous sickle cell disease detected at birth. Hemoglobin (2002) 0.76
Re: embryonic and fetal globins are expressed in adult erythroid progenitor cells and in erythroid cell cultures (Lau et al., Prenat Diagn 2001; 21: 529-539). Prenat Diagn (2002) 0.75
Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. Cochrane Database Syst Rev (2016) 0.75
The impact of trisomy 21 on early human hematopoiesis. Cell Cycle (2013) 0.75
Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major. J Pediatr Hematol Oncol (2016) 0.75
Red blood cell transfusion in neonates. Pediatrics (2005) 0.75
Regulatory and compliance activities to protect food-allergic consumers in Canada: research in support of standard setting and consumer protection. J AOAC Int (2005) 0.75
Pyruvate kinase (PK) deficiency in newborns: the pitfalls of diagnosis. J Pediatr (2007) 0.75
[Treatment with hydroxyurea has revolutionized the evolution of sickle cell disease ]. Rev Prat (2014) 0.75
Asymptomatic atrophy of the temporal median raphe of the retina associated with cerebral vasculopathy in homozygous sickle cell disease. J AAPOS (2012) 0.75
Managing the difficult case of fetal anemia. J Matern Fetal Neonatal Med (2011) 0.75